Esomeprazole and omeprazole may possibly boost the serum concentrations of benzodiazepines (by way of CYP2C19 inhibition) resulting in amplified adverse effects including drowsiness, although the clinical relevance is low for most clients – observe the client for adverse effects (e.If affected individual can not resume their standard oral medicat